Omic Pathways is a clinical education platform for the practitioners doing the hard, careful work of peptide therapy.
We teach the way the practice should be done: with real biochemistry, real literature, and the clinical judgment of faculty who see patients the next morning. The audience is licensed clinicians and the scientists who support them; the posture is academic, not promotional.
Membership is free. The paid layer, when it arrives, will be live cohorts with faculty, not a paywall on the fundamentals.
Editorial standard
Every module is authored by a working clinician paired with a bench scientist, cross-linked to primary literature, reviewed by a second pair of eyes, and refreshed on a twelve-month cadence. When the field changes, so do we.
How the curriculum is organized
The curriculum is structured by mechanism and body system, not by peptide brand. A clinician learning the GH axis can work Module 12 through 18 in sequence; one researching a single peptide enters through the molecular glossary and follows the cross-links. Both paths land in the same places.
Who is behind it
A small founding team of clinicians, scientists, and editors. Faculty and editorial leads are listed in the faculty directory. Contributions happen on a rolling basis; if you are a working practitioner with something to teach, we would like to talk to you.
Contact
Editorial: editorial@omicpathways.org. Everything else: contact@omicpathways.org.